Form D · Pharmaceuticals
Milestone Pharmaceuticals Inc.
Montreal, A8 · CIK 0001408443
Offering snapshot reported Oct 26, 2018 · SEC filing
- Reported sold
- $80M Offering amount: $80M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 15, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 26, 2018 | Initial | $80,000,000 | No comparison | 16 | SEC filing |
| Jul 25, 2017 | Initial | $6,880,072 | No comparison | 5 | SEC filing |
| Jun 15, 2015 | Initial | $3,848,369 | No comparison | 3 | SEC filing |
| Jun 14, 2011 | Initial | $595,502 | No comparison | 2 | SEC filing |
| Jul 30, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-324502
Source: Form D, filed Oct 26, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nathalie Beauregard | Executive |
| Cedric Bisson | Director |
| Marco Boorsma | Director |
| Ela Borenstein | Director |
| Benjamin Cowen | Executive |
| Philippe Douville | Executive |
| Dominic Jaikaran | Director |
| Nilesh Kumar | Director |
| Philippe Lamarre | Executive |
| Vincent Lesage | Executive |
| Debra Liebert | Director |
| Eric Linsley | Director |
| Dion Madsen | Director |
| Martin Maguire | Executive |
| Lorenz Muller | Executive |
| Jeff Nelson | Executive |
| Joseph G. Oliveto | Director, Executive |
| Harish Pimplaskar | Executive |
| Francis Plat | Executive |
| Yves Rosconi | Director |
| Guy Rousseau | Executive |
| Paul Truex | Director |
| Scott Weiner | Director |
| Douglas Wight | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1111 Dr. Frederik Philips Blvd Suite 420
Montreal, A8, H4M 2X6
Montreal, A8, H4M 2X6